Efmoroctocog alfa Recruiting Phase 4 Trials for Hemophilia As / Factor VIII (FVIII) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04690322POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies